Padrão de fundo
Zebinix 800 mg comprimidos

Zebinix 800 mg comprimidos

About the medicine

Como usar Zebinix 800 mg comprimidos

Introduction

Package Leaflet: Information for the User

Zebinix 800 mg Tablets

eslicarbazepine acetate

Read this package leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this package leaflet, as you may need to read it again.
  • If you have any questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others even if they have the same symptoms as you, as it may harm them.
  • If you experience any side effects, talk to your doctor or pharmacist. See section 4.

1. What is Zebinix and what is it used for

Zebinix contains the active ingredient eslicarbazepine acetate.

Zebinix belongs to a group of medications called antiepileptics, used to treat epilepsy, a disease where the affected person has seizures or repeated convulsive crises.

Zebinix is used:

  • as a single medication (monotherapy) in adult patients with newly diagnosed epilepsy;
  • in combination with other antiepileptic medications (adjunctive therapy) in adult, adolescent, and children over 6 years old who suffer from seizures (convulsions) affecting a part of the brain (partial seizures). These seizures may be followed or not by a seizure affecting the entire brain (secondary generalization).

Your doctor has prescribed Zebinix to reduce the number of seizures.

2. What you need to know before starting Zebinix

Do not take Zebinix:

  • if you are allergic to eslicarbazepine acetate, other carboxamide derivatives (such as carbamazepine or oxcarbazepine, used for the treatment of epilepsy), or any of the other components of this medication (listed in section 6);
  • if you have a certain type of heart rhythm disorder (second- or third-degree atrioventricular (AV) block).

Warnings and precautions

Consult your doctor or pharmacist before starting to take Zebinix.

Inform your doctor immediately:

  • if you experience blisters or peeling of the skin and/or mucous membranes, rash, difficulty swallowing or breathing, swelling of the lips, face, eyelids, throat, or tongue. These may be signs of an allergic reaction;
  • if you experience confusion, worsening of seizures, or decreased consciousness, which may be signs of low sodium levels in the blood.

Inform your doctor:

  • if you have kidney problems. Your doctor may need to adjust the dose. Zebinix is not recommended for patients with severe kidney disease;
  • if you have liver problems. Zebinix is not recommended for patients with severe liver disease;
  • if you are taking any medication that may cause an abnormality in the ECG (electrocardiogram) called prolonged PR interval. If you are unsure whether the medications you are taking may cause this effect, discuss it with your doctor;
  • if you have any heart disease, such as heart failure or myocardial infarction, or any alteration of heart rhythm;
  • if you have seizures that begin with a generalized electrical discharge affecting both sides of the brain.

A small number of people taking antiepileptic medications have had thoughts of self-harm or suicide. If this occurs while taking Zebinix, contact your doctor immediately.

Zebinix may cause dizziness and/or disorientation, particularly at the start of treatment. Be extra careful while taking Zebinix to avoid accidental injuries, such as falls.

Be extra careful with Zebinix

In the post-marketing experience, severe skin reactions and potentially life-threatening reactions, including Stevens-Johnson syndrome/toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported in patients treated with Zebinix.

If you develop a severe rash or other skin symptoms (see section 4), stop taking Zebinix and consult your doctor or seek medical attention immediately.

In patients of Thai origin and the Han Chinese ethnic group, the risk of severe skin reactions associated with carbamazepine or chemically related compounds may be predicted by a blood test. Your doctor will advise you on the need for this blood test before taking Zebinix.

Children

Zebinix should not be administered to children under 6 years of age.

Taking Zebinix with other medications

Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication. This is to ensure that none of them interfere with the way Zebinix works, or that Zebinix interferes with the effect of such medications. Inform your doctor if you are taking:

  • phenytoin (a medication used for the treatment of epilepsy), as you may need to adjust the dose;
  • carbamazepine (a medication used for the treatment of epilepsy), as you may need to adjust the dose, and the following Zebinix side effects may occur more frequently: double vision, abnormal coordination, and dizziness;
  • hormonal contraceptives (such as the birth control pill), as Zebinix may reduce their effectiveness;
  • simvastatin (a medication used to reduce cholesterol levels), as you may need to adjust the dose;
  • rosuvastatin, a medication used to reduce cholesterol levels;
  • the anticoagulant warfarin;
  • monoamine oxidase inhibitors (MAOIs);
  • do not take oxcarbazepine (a medication used for the treatment of epilepsy) with Zebinix, as it is unknown whether it is safe to take these two medications together.

See the section “Pregnancy and breastfeeding” for recommendations on contraception.

Pregnancy and breastfeeding

Zebinix is not recommended for use during pregnancy, as the effects of Zebinix on pregnancy and the fetus are unknown.

If you plan to become pregnant, discuss this with your doctor before stopping your contraceptive method and before becoming pregnant. Your doctor may decide to change your treatment.

There is limited data on the use of eslicarbazepine acetate in pregnant women.

Research has shown an increased risk of congenital defects and neurological development problems (brain development) in children of women taking antiepileptic medications, particularly when taking more than one antiepileptic medication at a time.

If you are or think you may be pregnant, inform your doctor immediately. Do not stop taking your medication until you have discussed this with your doctor. Stopping your medication without consulting your doctor may cause seizures, which can be dangerous for you and your unborn child. Your doctor may decide to change your treatment.

If you are a fertile woman and do not plan to become pregnant, use an effective contraceptive method during treatment with Zebinix. Zebinix may affect the functioning of hormonal contraceptives, such as the birth control pill, and make them less effective in preventing pregnancy. Therefore, it is recommended to use other forms of safe and effective contraception while taking Zebinix.Discuss this with your doctor, who will discuss with you the type of contraceptive most suitable for use while taking Zebinix. If you stop taking Zebinix, continue using an effective contraceptive method until the end of the current menstrual cycle. If you take Zebinix during pregnancy, your baby may also be at risk of bleeding immediately after birth. Your doctor may give you and your baby a medication to prevent this.

Do not breastfeed while taking Zebinix. It is unknown whether it passes into breast milk.

Driving and operating machinery

Zebinix may cause dizziness, disorientation, and affect your vision, particularly at the start of treatment. If this occurs, do not drive or use any tools or machinery.

3. How to take Zebinix

Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.

Adults

Initial treatment dose

400 mg once a day for one or two weeks, before increasing to the maintenance dose. Your doctor will decide if you should take this dose for one or two weeks.

Maintenance dose

The usual maintenance dose is 800 mg once a day.

The dose may be increased to 1,200 mg once a day based on how you respond to Zebinix. If you are taking Zebinix alone (monotherapy), your doctor may consider increasing your dose to 1,600 mg once a day.

Patients with kidney problems

If you have kidney problems, you will usually be given a lower dose of Zebinix. Your doctor will determine the correct dose for you. Zebinix is not recommended if you have severe kidney problems.

Older adults (65 years and older)

If you are an older adult and taking Zebinix as monotherapy, the 1,600 mg dose is not suitable for you.

Children over 6 years old

Initial treatment dose

The initial dose is 10 mg per kg of body weight once a day for one or two weeks, before increasing to the maintenance dose.

Maintenance dose

The dose may be increased by 10 mg per kg of body weight, at intervals of one or two weeks, up to 30 mg per kg of body weight. The maximum dose is 1,200 mg once a day.

Children ≥ 60 kg

Children with a body weight of 60 kg or more should take the same dose as adults.

The oral suspension, another pharmaceutical form of the medication, may be more suitable for administration in children. Consult your doctor or pharmacist.

Form and route of administration

Zebinix is administered orally. Swallow the tablet with a glass of water.

Zebinix can be taken with or without food.

If you have difficulty swallowing the entire tablet, you can crush it and add it to a small amount of water or apple sauce to take it immediately.

The tablet can be divided into equal doses.

If you take more Zebinix than you should

If you accidentally take more Zebinix than you should, you are at risk of having more seizures; or you may feel that your heartbeat is irregular or faster. Contact your doctor or go immediately to a hospital if you experience any of these symptoms. Bring the medication packaging with you, so the doctor knows what you have taken.

If you forget to take Zebinix

If you forget to take a tablet, take it as soon as you remember and continue as usual. Do not take a double dose to make up for the missed doses.

If you interrupt treatment with Zebinix

Do not suddenly stop taking the tablets. If you do, you are at risk of having more seizures. Your doctor will decide for how long you should take Zebinix. If your doctor decides to stop your treatment with Zebinix, you will usually be gradually reduced the dose. It is essential that you complete the treatment as instructed by your doctor; otherwise, your symptoms may worsen.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

4. Possible Adverse Effects

Like all medicines, this medicine can cause side effects, although not everyone will experience them.

The following side effects can be very serious. If they occur, stop taking Zebinix and inform your doctor or go to the hospital immediately, as you may need urgent medical treatment:

  • blistering or peeling of the skin and/or mucous membranes, rash, difficulty swallowing or breathing, swelling of the lips, face, eyelids, throat, or tongue. These could be signs of an allergic reaction.

The side effectsvery common(can affect more than 1 in 10 people) are:

  • dizziness or somnolence.

The side effectscommon(can affect up to 1 in 10 people) are:

  • feeling of instability, or feeling like you are spinning or floating;
  • nausea or vomiting;
  • headache;
  • diarrhea;
  • double vision or blurred vision;
  • difficulty concentrating;
  • feeling of fatigue or decreased energy;
  • tremor;
  • skin rash;
  • blood tests showing low sodium levels;
  • decreased appetite;
  • difficulty sleeping;
  • difficulty with coordination of movements (ataxia);
  • weight gain.

The side effectsuncommon(can affect up to 1 in 100 people) are:

  • clumsiness of movements;
  • allergy;
  • constipation;
  • seizures;
  • underactive thyroid gland. Symptoms include decreased levels of thyroid hormones (detected in blood tests), intolerance to cold, increased size of the tongue, nails, or hair, and low body temperature;
  • liver problems(such as increased liver enzymes);
  • high blood pressure or intense increase in blood pressure;
  • low blood pressure, or blood pressure decreased when standing;
  • blood tests showing low levels of salts (including chloride), or a decrease in the number of red blood cells;
  • dehydration;
  • changes in eye movements, blurred vision, or red eyes;
  • experiencing falls;
  • burns;
  • extreme drowsiness;
  • sedation;
  • neurological motor disorder where muscles contract, causing twisting and repetitive movements or abnormal postures. Symptoms include tremors, pain, and cramps;
  • medication toxicity;
  • anxiety.

The side effects ofunknown frequency(cannot be estimated from available data) are:

  • reduction of platelets that increases the risk of bleeding or hematomas;
  • intense pain in the back or stomach (caused by inflammation of the pancreas);
  • reduction of white blood cells that makes infections more likely;
  • red or circular patches often with central blisters on the trunk, peeling of the skin, mouth ulcers, throat, nose, genitals, and eyes, red and inflamed eyes that may be preceded by fever and/or symptoms similar to the flu (Stevens-Johnson syndrome/toxic epidermal necrolysis);
  • initially symptoms similar to the flu, rash on the face, generalized rash, elevated body temperature, elevated liver enzymes, blood abnormalities (eosinophilia), enlarged lymph nodes, and other body conditions (drug reaction with eosinophilia and systemic symptoms, also known as DRESS or drug hypersensitivity syndrome);
  • severe allergic reaction that causes swelling of the face, throat, hands, feet, ankles, or lower legs;
  • urticaria (skin rash with itching);
  • lethargy, confusion, muscle spasms, or a significant worsening of seizures (possible symptoms of low sodium levels in the blood due to inadequate secretion of the antidiuretic hormone (ADH)).

The use of Zebinix is associated with an ECG anomaly called an increase in the PR interval. Side effects associated with this ECG anomaly (such as fainting and slowing of heart rate) may occur.

Bone disorders, including osteopenia and osteoporosis (bone thinning), and fractures have been reported with antiepileptic drugs structurally related to carbamazepine and oxcarbazepine. Talk to your doctor or pharmacist if you are on long-term treatment with antiepileptics, have a history of osteoporosis, or take steroids.

Reporting of side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the national notification system included in theAppendix V. By reporting side effects, you can contribute to providing more information on the safety of this medicine.

5. Conservation of Zebinix

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date that appears on the blister pack, bottle, and box after the letters CAD. The expiration date is the last day of the month indicated.

No special storage conditions are required.

Medicines should not be disposed of through drains or in the trash. Ask your pharmacist how to dispose of the packaging and medications that you no longer need. In this way, you will help protect the environment.

6. Contents of the packaging and additional information

Composition of Zebinix

  • The active ingredient is eslicarbazepine acetate. Each tablet contains 800 mg of eslicarbazepine acetate.
  • The other components are povidone K29/32, croscarmellose sodium, and magnesium stearate.

Appearance of the product and contents of the pack

Zebinix 800 mg tablets are white and oblong, with a length of 19 mm. The tablets have the inscription “ESL 800” engraved on one face and are scored on the opposite side. The tablet can be divided into equal doses.

The tablets are packaged in blisters, in cardboard boxes of 20, 30, 60, or 90 tablets, or in multiple packs containing 180 (2 x 90) tablets, and in HDPE bottles with child-resistant closures, in cardboard boxes of 90 tablets.

Only some pack sizes may be marketed.

Marketing authorization holder and manufacturer responsible

BIAL - Portela & Cª, S.A., À Av. da Siderurgia Nacional,

4745-457 S. Mamede do Coronado

Portugal

telephone: +351 22 986 61 00

fax: +351 22 986 61 99

email: [email protected]

Further information about this medicinal product can be obtained by contacting the local representative of the marketing authorization holder:

About the medicine

Quanto custa o Zebinix 800 mg comprimidos em Espanha em 2025?

O preço médio do Zebinix 800 mg comprimidos em julho de 2025 é de cerca de 92.06 EUR. Os valores podem variar consoante a região, a farmácia e a necessidade de receita. Confirme sempre com uma farmácia local ou fonte online para obter informações atualizadas.

Consulte um médico online

Tem perguntas sobre este medicamento ou sintomas? Obtenha orientação de um médico qualificado, de forma prática e segura.

0.0(9)
Doctor

Anna Moret

Dermatologia18 anos de experiência

A Dra. Anna Moret é dermatologista e dermatovenerologista certificada, especializada em dermatologia para adultos e crianças, venereologia, cuidados estéticos com a pele e medicina geral. As suas consultas são baseadas em evidências e adaptadas às necessidades dermatológicas individuais de cada paciente.

A Dra. Moret realiza avaliação e tratamento especializado para:

• Problemas de pele como eczema, acne, rosácea, dermatite e psoríase • Queda de cabelo, caspa e dermatite seborreica do couro cabeludo • Dermatologia pediátrica — do recém-nascido à adolescência • Infeções sexualmente transmissíveis (DSTs) e dermatovenereologia • Envelhecimento da pele e tratamentos estéticos não invasivos • Alergias cutâneas e reações de hipersensibilidade • Avaliação de sinais, lesões cutâneas e rastreio de cancro de pele • Aconselhamento sobre cuidados com a pele e rotinas personalizadas com dermocosméticos

Combinando conhecimentos em dermatologia e medicina geral, a Dra. Moret oferece um cuidado abrangente, focado tanto na saúde da pele como nas possíveis causas associadas. Possui também certificação do Canadian Board of Aesthetic Medicine, assegurando uma abordagem estética alinhada com os padrões internacionais.

CameraMarcar consulta online
5.0(56)
Doctor

Alina Thurman

Medicina familiar12 anos de experiência

A Dra. Alina Tsurkan é médica de clínica geral e familiar licenciada em Portugal, oferecendo consultas online para adultos e crianças. O seu trabalho centra-se na prevenção, diagnóstico preciso e acompanhamento a longo prazo de condições agudas e crónicas, com base em medicina baseada na evidência.

A Dra. Tsurkan acompanha pacientes com uma ampla variedade de queixas de saúde, incluindo: • Infeções respiratórias: constipações, gripe, bronquite, pneumonia, tosse persistente • Problemas otorrinolaringológicos: sinusite, amigdalite, otite, dor de garganta, rinite alérgica • Queixas oftalmológicas: conjuntivite alérgica ou infeciosa, olhos vermelhos, irritação ocular • Problemas digestivos: refluxo ácido (DRGE), gastrite, síndrome do intestino irritável (SII), obstipação, inchaço abdominal, náuseas • Saúde urinária e reprodutiva: infeções urinárias, cistite, prevenção de infeções recorrentes • Doenças crónicas: hipertensão, colesterol elevado, controlo de peso • Queixas neurológicas: dores de cabeça, enxaquecas, distúrbios do sono, fadiga, fraqueza geral • Saúde infantil: febre, infeções, problemas digestivos, seguimento clínico, orientação sobre vacinação

Outros serviços disponíveis: • Atestados médicos para a carta de condução (IMT) em Portugal • Aconselhamento preventivo e consultas de bem-estar personalizadas • Análise de resultados de exames e relatórios médicos • Acompanhamento clínico e revisão de medicação • Gestão de comorbilidades e situações clínicas complexas • Prescrições e documentação médica à distância

A abordagem da Dra. Tsurkan é humanizada, holística e baseada na ciência. Trabalha lado a lado com cada paciente para desenvolver um plano de cuidados personalizado, centrado tanto nos sintomas como nas causas subjacentes. O seu objetivo é ajudar cada pessoa a assumir o controlo da sua saúde com acompanhamento contínuo, prevenção e mudanças sustentáveis no estilo de vida.

CameraMarcar consulta online
5.0(90)
Doctor

Andrei Popov

Clínica geral6 anos de experiência

O Dr. Andrei Popov é um médico licenciado em medicina geral e especialista em controlo da dor, com prática clínica em Espanha. Oferece consultas online para adultos com dor aguda ou crónica, bem como para uma variedade de queixas médicas comuns.

É especializado no diagnóstico e tratamento de condições dolorosas que afetam a qualidade de vida, incluindo: • Dor crónica com duração superior a 3 meses • Enxaquecas e dores de cabeça recorrentes • Dores no pescoço, costas, região lombar e articulações • Dor pós-traumática após lesões ou cirurgias • Dor neuropática, fibromialgia e nevralgias

Além do controlo da dor, o Dr. Popov também presta cuidados médicos em casos como: • Infeções respiratórias (constipações, bronquite, pneumonia) • Hipertensão arterial e condições metabólicas, como a diabetes • Acompanhamento preventivo e check-ups de rotina

As consultas online duram até 30 minutos e incluem uma avaliação detalhada dos sintomas, plano de tratamento personalizado e seguimento médico, se necessário.

A abordagem do Dr. Popov baseia-se na medicina baseada na evidência, com atenção individualizada à história clínica, estilo de vida e necessidades específicas de cada paciente.

CameraMarcar consulta online
5.0(21)
Doctor

Yevgen Yakovenko

Cirurgia geral11 anos de experiência

Dr. Yevgen Yakovenko é um cirurgião e clínico geral licenciado em Espanha e Alemanha. É especializado em cirurgia geral, pediátrica e oncológica, medicina interna e controlo da dor. Oferece consultas online para adultos e crianças, combinando precisão cirúrgica com acompanhamento terapêutico. O Dr. Yakovenko acompanha pacientes de vários países e presta cuidados médicos em ucraniano, russo, inglês e espanhol.

Áreas de especialização médica: • Dor aguda e crónica: cefaleias, dores musculares e articulares, dores nas costas, dores abdominais, dor pós-operatória. Identificação da causa, plano de tratamento e seguimento. • Medicina interna: coração, pulmões, trato gastrointestinal, sistema urinário. Controlo de doenças crónicas, alívio de sintomas, segunda opinião. • Cuidados pré e pós-operatórios: avaliação de riscos, apoio na tomada de decisão, acompanhamento após cirurgia, estratégias de reabilitação. • Cirurgia geral e pediátrica: hérnias, apendicite, doenças congénitas. Cirurgias programadas e de urgência. • Traumatologia: contusões, fraturas, entorses, lesões de tecidos moles, tratamento de feridas, pensos, encaminhamento para cuidados presenciais quando necessário. • Cirurgia oncológica: revisão diagnóstica, planeamento do tratamento, acompanhamento a longo prazo. • Interpretação de exames: análise de ecografias, TAC, ressonâncias magnéticas e radiografias. Planeamento cirúrgico com base nos resultados. • Segundas opiniões e navegação médica: esclarecimento de diagnósticos, revisão de tratamentos atuais, apoio na escolha do melhor caminho terapêutico.

Experiência e formação: • Mais de 12 anos de experiência clínica em hospitais universitários na Alemanha e em Espanha • Formação internacional: Ucrânia – Alemanha – Espanha • Membro da Sociedade Alemã de Cirurgiões (BDC) • Certificação em diagnóstico por imagem e cirurgia robótica • Participação ativa em congressos médicos e investigação científica internacionais

O Dr. Yakovenko explica temas médicos complexos de forma clara e acessível. Trabalha em parceria com os pacientes para analisar situações clínicas e tomar decisões fundamentadas. A sua abordagem baseia-se na excelência clínica, rigor científico e respeito individual.

Se tem dúvidas sobre um diagnóstico, está a preparar-se para uma cirurgia ou quer discutir resultados de exames, o Dr. Yakovenko pode ajudá-lo a avaliar as suas opções e avançar com confiança.

CameraMarcar consulta online
Ver todos os médicos

Receba novidades da plataforma e promoções exclusivas

Fique a par das atualizações da Oladoctor e receba promoções exclusivas para subscritores.

Siga-nos nas redes sociais
FacebookInstagramTikTok

België/Belgique/Belgien

BIAL-Portela & Cª., S.A.

Tel/Tel: + 351 22 986 61 0

(Portugal)

Luxembourg/Luxemburg

BIAL-Portela & Cª., S.A.

Tel/Tel: + 351 22 986 61 00

(Portugal)

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.

...

(...

...

BIAL-Portela & Cª., S.A.